[Covid-19] Sanofi is proud to be part of the Bill & Melinda Gates Foundation consortium to fight Covid-19

Sanofi is proud to be part of the Bill & Melinda Gates Foundation consortium to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments to fight Covid-19. 

'On 25 March 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19. The life sciences industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions to the pandemic, which is affecting billions worldwide. The impact on health systems, economies, and livelihoods is profound, and an effective response requires an unprecedented collaboration across governments, academia, the private sector, and the philanthropic community.

[...]

Companies participating in the collaboration include BD, bioMérieux, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck (known as MSD outside the U.S. and Canada), Merck KGaA, Novartis, Pfizer, and Sanofi.'

Read More

 

About Sanofi

At Sanofi, our passion is to prevent, treat and cure illness and disease throughout life. We are driven to improve the health of communities and to find new solutions for patients by combining break-through science with advanced technology. We are always working to find new ways to fight chronic, complex and rare diseases with medicines that offer hope for patients in the future of healthcare.

Related articles

No news available.

Evénements sur le même thème

Share this page Share on FacebookShare on TwitterShare on Linkedin

COVID-19 COLLABORATIVE PLATFORM

Close

COVID-19 COLLABORATIVE PLATFORM